Nok Therapeutics, Inc.

Form D Filings

Industry Group
Biotechnology
Entity Type
Corporation
CIK
0002038166
All SEC Filings
View on sec.gov
Date Filed Security Types Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
10/24/2025 Equity $250,500 Indefinite Indefinite 10/8/2024 10/24/2025 D 000121390025102039
10/24/2025 Equity $566,500 $750,000 $183,500 8/6/2024 10/24/2025 D 000121390025102036